Russia claims to have solved problem of counterfeit meds in domestic market – The Pharma Letter

06-10-2022 Comments (0)Print
22-12-2021
25-05-2021
23-02-2021
06-10-2022
29-09-2022
28-09-2022
Russia claims to have solved problem of counterfeit meds in domestic market

The share of counterfeit medicines in the Russian pharmaceutical market has declined to minimal figures in the last five years, which was mainly due to efforts that have been made by the state, according to a recent report published by the Russian pharmaceutical regulator Roszdravnadzor and some local media, reports The Pharma Letter’s local correspondent.
A representative of Roszdravnadzor has said that, “over the past five years, the…


This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
 
• All the news that moves the needle in pharma and biotech.
• Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
• Receive The Pharma Letter daily news bulletin, free forever.

• Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
• Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
• Daily roundup of key events in pharma and biotech.
• Monthly in-depth briefings on Boardroom appointments and M&A news.
• Choose from a cost-effective annual package or a flexible monthly subscription.
All therapy areasCounterfeit productsFocus OnFrom our correspondentIn DepthPharmaceuticalRussiaRussian market
The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.
The Pharma Letter
39 to 43 Putney High Street
Putney
London
SW15 1SP
For trial and subscription enquiries please email [email protected]
For editorial enquiries, press releases and events please email [email protected]
For all other queries please email [email protected]
Agile web development by Byte9
Back to top

source

Add a Comment

Your email address will not be published. Required fields are marked *